FUNDAMENTALS · Fundamentals · CN Healthcare

Aurora Optoelectronics (600666) Fundamentals 2026 — P/E 47.1x, Revenue Analysis | SniperIQ

Aurora Optoelectronics (600666) is a CN-listed Healthcare company in Drug Manufacturers - General with a market capitalization of ¥8.7B, trading at ¥3.18 on the SHH. This SniperIQ fundamentals page covers Aurora Optoelectronics's valuation (P/E 47.1x, P/B 8.0x), profitability (net margin 28.8%), revenue (¥465M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap¥8.7B
P/E (TTM)47.1x
Net Margin28.8%
Revenue (FY25)¥465M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Aurora Optoelectronics's market cap?

Aurora Optoelectronics (600666) has a market capitalization of approximately ¥8.7B, trading at ¥3.18 on the SHH. Market cap moves with the live share price.

What is Aurora Optoelectronics's P/E ratio?

Aurora Optoelectronics's trailing twelve-month P/E ratio is 47.1x, with a price-to-book (P/B) of 8.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Aurora Optoelectronics?

Aurora Optoelectronics runs a net profit margin of 28.8%, a gross margin of 14.8%, and an operating margin of -10.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Aurora Optoelectronics generate?

Aurora Optoelectronics reported revenue of ¥465M for fiscal year 2025, with net income of ¥141M and earnings per share (EPS) of 0.0519. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Aurora Optoelectronics pay a dividend?

Aurora Optoelectronics does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Aurora Optoelectronics financially healthy?

Aurora Optoelectronics carries a debt-to-equity ratio of 0.36x and a current ratio of 1.27x, with a market beta of -0.26. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Aurora Optoelectronics a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Aurora Optoelectronics (600666) the key facts are: market cap ¥8.7B, P/E 47.1x, revenue ¥465M, 52-week range 2.81-7.57. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Aurora Optoelectronics's full fundamentals live

Get Aurora Optoelectronics's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Protagonist Therapeutics (PTGX) fundamentals · Ionis Pharmaceuticals (IONS) fundamentals · Sansure Biotech (688289) fundamentals · NeoImmuneTech (950220) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons